Endothelial dysfunction and improvement of the angiotensin II-reactivity in hypercholesterolemic rabbits: role of cyclooxygenase metabolites.

作者: Susana Jerez , Liliana Sierra , Alfredo Coviello , Maria Peral de Bruno

DOI: 10.1016/J.EJPHAR.2007.10.037

关键词:

摘要: Abstract The aim of this paper was to study the effect high cholesterol diet on endothelial function and vascular reactivity angiotensin II test role vasoconstrictor cyclooxygenase metabolites in experimental condition. Rabbits were fed with either normal chow or a containing 1% for 6–7-week. Isometric contractions measured rubbed unrubbed aortic rings. Arteries contracted noradrenaline then exposed one cumulative dose–response curve acetylcholine absence (control) presence indomethacin, ( N -[2-cyvlohexyloxy)-4-nitrophenyl]-methanesulfonamide) (NS 398) 4-hydroxy-2,2,6,6-tetraethylpiperidine- -oxyl (tempol). After washing arteries, constructed NS 398, [1 S -[1 alpha,2 beta (5 Z ),3 beta,4 alpha]-7-[3-[[2-[(phenylamino) carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1] hept-2-yl]-5-heptenoic acid (SQ29548) 17-octadecynoic (17-ODYA). In other group, resting potential recorded basal II-stimulated conditions. Indomethacin, 398 17-ODYA added bath before II-stimulation. enriched showed higher plasma levels total LDL. Hypercholesterolemic impaired relaxation. Indomethacin normalized endothelium-dependent relaxation whereas tempol had no phenomenon. Angiotensin II-reactivity increased endothelium intact hypercholesterolemic rings SQ29548 blocked effect. arteries significantly less negative control after but not indomethacin prevented II-depolarization. High caused dysfunction II-reactivity. Both effects cyclooxygenase1-dependent. Deficit NO-production might improve 20-hydroxyeicosatrienoic availability, which induces depolarization II-sensitization. addition, would be metabolized by cyclooxygenase1 20-endoperoxides act through thromboxane A 2 /prostaglandin H receptors contributing increase.

参考文章(32)
M L Schwartzman, J R Falck, P Yadagiri, B Escalante, Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites. Journal of Biological Chemistry. ,vol. 264, pp. 11658- 11662 ,(1989) , 10.1016/S0021-9258(18)80115-6
Richard J. Roman, P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiological Reviews. ,vol. 82, pp. 131- 185 ,(2002) , 10.1152/PHYSREV.00021.2001
Mairead A. Carroll, Michal Schwartzman, Jorge Capdevila, J.R. Falck, John C. McGiff, Vasoactivity of arachidonic acid epoxides European Journal of Pharmacology. ,vol. 138, pp. 281- 283 ,(1987) , 10.1016/0014-2999(87)90445-6
Carl A Gruetter, Errol T Ryan, Sally M Lemke, Dianne A Bailly, M Kathleen Fox, Darryle D Schoepp, None, Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels. European Journal of Pharmacology. ,vol. 146, pp. 85- 95 ,(1988) , 10.1016/0014-2999(88)90489-X
Alison Blair, Philip W. Shaul, Ivan S. Yuhanna, Patricia A. Conrad, Eric J. Smart, Oxidized Low Density Lipoprotein Displaces Endothelial Nitric-oxide Synthase (eNOS) from Plasmalemmal Caveolae and Impairs eNOS Activation Journal of Biological Chemistry. ,vol. 274, pp. 32512- 32519 ,(1999) , 10.1074/JBC.274.45.32512
Susana Jerez, Maria Peral de Bruno, Alfredo Coviello, Nitric oxide modulates angiotensin II-induced endothelial vasoconstrictor prostanoid release European Journal of Pharmacology. ,vol. 520, pp. 127- 134 ,(2005) , 10.1016/J.EJPHAR.2005.07.030
M Mistry, A Nasjletti, Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension. Hypertension. ,vol. 11, pp. 758- 762 ,(1988) , 10.1161/01.HYP.11.6.758
Debebe Gebremedhin, Andrew R. Lange, Jayashree Narayanan, Mikael R. Aebly, Elizabeth R. Jacobs, David R. Harder, Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current The Journal of Physiology. ,vol. 507, pp. 771- 781 ,(1998) , 10.1111/J.1469-7793.1998.771BS.X
P. Poredoš, Endothelial dysfunction and cardiovascular disease. Pathophysiology of Haemostasis and Thrombosis. ,vol. 32, pp. 274- 277 ,(2002) , 10.1159/000073580